JoachimHannoIxMD

Hypertension

Professor, Medicine, University of California San Diego School of Medicine // Chief, Division of Nephrology-Hypertension

Dr. Ix is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

I am a board certified nephrologist, epidemiologist, and clinical trialist at UC San Diego Health. My research focuses in two main areas, novel therapies chronic kidney disease mineral bone disorders (CKD-MBD), and non-invasive assessment of kidney tubule health. My team and I have evaluated a myriad of blood and urine proteins that non-invasively assess the health of kidney tubule cells, and are working to determine if these markers improve assessment of risk of future kidney disease progression and cardiovascular disease risk.

University of California (San Francisco)Fellowship, Nephrology, 2004 - 2006
University of California (San Francisco)Residency, Internal Medicine, 2000 - 2003
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2000

PubMed

Static histomorphometry parameters can identify bone turnover status in children and adults with chronic kidney disease.
Jan M Hughes-Austin, Renata C Pereira, Vanda D Jorgetti, Isidro B Salusky, Joachim H Ix
Bone. 2025-01-01
1 citations
Association of Blood Mitochondrial DNA Copy Number With Risk of Acute Kidney Injury After Cardiac Surgery.
Vasantha Jotwani, Heather Thiessen-Philbrook, Dan E Arking, Stephanie Y Yang, Eric McArthur
American Journal of Kidney Diseases. 2025-01-01
The Association of Plasma and Urine Uromodulin With Cardiovascular Disease in Persons With Hypertension and CKD.
Jesse C Ikeme, Rebecca Scherzer, Pranav S Garimella, Stein I Hallan, Ronit Katz
American Journal of Kidney Diseases. 2024-12-01

Journal Articles

PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT
Udayan Y Bhatt, Clinton B Wright, Vasilios Papademetriou, Joachim H Ix, Michael G Shlipak, Alfred K Cheung, Mark J Sarnak, Jing Chen, Charles Ginsberg, Glenn M Chertow..., Journal of the American Society of Nephrology
Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case–Control Study
Paul Drawz, Joachim H Ix, Michel Chonchol, Mark J Sarnak, Chirag R Parikh, Michael G Shlipak, Alfred K Cheung, Annals of Internal Medicine
Acute Declines in Renal Function During Intensive BP Lowering and Long-Term Risk of Death
Kenneth Jamerson, Mark J Sarnak, Miroslaw Smogorzewski, Joachim H Ix, Journal of the American Society of Nephrology

Lectures

Kidney, Bone, and Vasculature: Is the Gut a New Piece of the Puzzle?
American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019

KDIGO Launches Guideline Fellowship ProgramNovember 1st, 2024
Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINTOctober 2nd, 2019
Correlates of T50 and Relationships with Bone Mineral Density in Community-Living Older Men: The Osteoporotic Fractures in Men (MrOS) StudyMarch 20th, 2019
Join now to see all

Fetuin-A And Incident Cardiovascular Disease, Fracture, And DiabetesNational Heart, Lung, And Blood Institute2009–2011
Determinants And Cardiovascular Consequences Of Diabetes In Older AdultsNational Heart, Lung, And Blood Institute2009–2011
Fetuin-A: A Novel Biomarker Of Vascular Calcification And Diabetes MellitusNational Heart, Lung, And Blood Institute2009–2010